[2011 Round-Up] Epilepsy: new epidemiological and therapeutic perspectives
Source: Lancet
In 2011, research in epilepsy has been remarkable because it has pushed the boundaries of data collection, either by expanding the duration of prospective follow-up or by including unmatched numbers of patients in double-blind randomised trials, observational studies, or meta-analyses. As a result, important findings have been reported, particularly in the areas of sudden unexplained death in epilepsy (SUDEP) and teratogenicity.